Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Schizophrenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00859872
What this trial is testing

Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in Schizophrenia

Who this might be right for
Schizophrenia
Central South University 198
Large-scale testing (Phase 3)Study completedNCT00309699
What this trial is testing

Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder

Who this might be right for
Bipolar DisorderMood Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 493
Large-scale testing (Phase 3)Ended earlyNCT00645229
What this trial is testing

The Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1
Not applicableUnknownNCT03873922
What this trial is testing

Ketogenic Diet for Psychotic Disorders

Who this might be right for
Psychosis; AcutePsychosisPsychotic Disorders+1 more
Kuopio University Hospital 40
Large-scale testing (Phase 3)Study completedNCT00712686
What this trial is testing

Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 690
Testing effectiveness (Phase 2)Ended earlyNCT01491490
What this trial is testing

Treatment on Iatrogenic Weight Gain and Dyslipidaemia Associated With Olanzapine

Who this might be right for
Schizophrenia
GW Research Ltd 2
Large-scale testing (Phase 3)Study completedNCT01104779
What this trial is testing

Safety and Efficacy of Cariprazine in Schizophrenia

Who this might be right for
Schizophrenia
Forest Laboratories 446
Large-scale testing (Phase 3)Study completedNCT03345979
What this trial is testing

Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
Alkermes, Inc. 200
Post-approval studies (Phase 4)Ended earlyNCT00418873
What this trial is testing

Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward

Who this might be right for
Schizophrenia
Astellas Pharma Inc 39
Large-scale testing (Phase 3)UnknownNCT05803642
What this trial is testing

Olanzapine in Patients With Acute Agitation

Who this might be right for
Acute Agitation
Qilu Pharmaceutical Co., Ltd. 318
Not applicableEnded earlyNCT01465074
What this trial is testing

Effects of Acute Nicotine Treatment on Neuroplasticity and Memory in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Centre for Addiction and Mental Health 20
Large-scale testing (Phase 3)Study completedNCT01617187
What this trial is testing

The Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688)

Who this might be right for
Schizophrenia
Organon and Co 360
Large-scale testing (Phase 3)Study completedNCT04092686
What this trial is testing

A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 464
Post-approval studies (Phase 4)Study completedNCT00140166
What this trial is testing

Treatment of Acute Schizophrenia With Vitamin Therapy

Who this might be right for
Acute Schizophrenia
Beersheva Mental Health Center 55
Not applicableStudy completedNCT01544608
What this trial is testing

Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 1,076
Post-approval studies (Phase 4)UnknownNCT00838032
What this trial is testing

Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With Schizophrenia

Who this might be right for
Acute Schizophrenia
Sichuan University 70
Large-scale testing (Phase 3)Study completedNCT00240721
What this trial is testing

The Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder

Who this might be right for
Bipolar DisordersMood DisordersAffective Disorders, Psychotic
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 363
Not applicableLooking for participantsNCT07836348
What this trial is testing

A Closed Unit Incorporating Soteria Elements Versus a Conventional Closed Psychiatric Ward

Who this might be right for
Psychotic Disorders
Jerusalem Mental Health Center 200
Post-approval studies (Phase 4)Study completedNCT00304655
What this trial is testing

Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS)

Who this might be right for
SchizophreniaSchizoaffective Disorder
Korea Otsuka Pharmaceutical Co., Ltd. 300
Testing effectiveness (Phase 2)Study completedNCT07550387
What this trial is testing

A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Schizophrenia

Who this might be right for
SCHIZOPHRENIA 1 (Disorder)
Jiangsu Hansoh Pharmaceutical Co., Ltd. 363
Next Page